Madrigal Pharmaceuticals stockMDGL
Madrigal Pharmaceuticals trades at $400.10, 34.9% below its 52-week high (Dec 24, 2025). The price is below its 50- and 200-day averages, a downtrend. −31.3% year to date, −15.9% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 25, 2027.
Ratings, candles, signals and the screener for MDGL — after you log in
Open the terminalFrequently asked questions about Madrigal Pharmaceuticals
What is the Madrigal Pharmaceuticals stock price?
At the close on Nov 5, 2026: $400.10 (−0.08% on the day). 52-week high: $615.00 on Dec 24, 2025. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Madrigal Pharmaceuticals report earnings?
The next quarterly report is on Feb 25, 2027. Last quarter, earnings per share changed +136% year over year, revenue +50%.
Does Madrigal Pharmaceuticals pay dividends?
No, Madrigal Pharmaceuticals does not pay dividends.
Where does Madrigal Pharmaceuticals trade and how to buy it?
Ticker MDGL, exchange Nasdaq, listed since 2007. You can buy it through a broker with access to US exchanges.
Should I buy Madrigal Pharmaceuticals now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for MDGL are in the terminal after you log in.